Matches in SemOpenAlex for { <https://semopenalex.org/work/W1765288714> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W1765288714 endingPage "981" @default.
- W1765288714 startingPage "977" @default.
- W1765288714 abstract "Thirty-five eligible patients with disseminated malignant melanoma received intramuscular recombinant leukocyte interferon (IFN-rA), 50 X 10(6) U/m2 three times weekly (TIW) for an intended duration of 12 weeks concomitant with daily oral cimetidine, 1,200 mg/d in four divided doses. For all study participants, the median survival time was six months. Among 21 good risk patients (performance score [PS] 0, 1 and no prior chemotherapy), we observed seven partial regressions (33%). Six patients had stability of disease (29%), seven had immediate disease progression, and one discontinued treatment after two doses without tumor evaluation due to side effects. Times to disease progression of five patients with regressions of soft-tissue disease were 2.1, 3.3, 3.5, 3.7, and 4.3 months. Two patients had partial regressions of lung nodules for 2.0 and 3.8 months. We observed one regression among 14 poor risk patients (PS 2, 3, or prior chemotherapy). A 46-year-old woman with prior treatment had a partial regression of soft-tissue disease for 4.1 months. Four poor risk patients achieved disease stability, and nine progressed immediately. Leukopenia (WBC count less than 4,100/microL) affected 21 (66%) of 32 patients with WBC count data. The median count was 3,100/microL; range, 1,300 to 8,400/microL. We detected two cases of mild thrombocytopenia (100,000 and 120,000/microL). Other noteworthy toxicities included moderate-to-severe nausea (34%), anorexia (63%), and fatigue (80%). All patients experienced myalgias. Twenty patients had dosage decreases during the first cycle, and 14 of the 16 patients remaining on study after the first cycle required dosage reductions. The overall response rate is similar to our prior studies with IFN-rA as a single agent using TIW doses of 50 X 10(6) U/m2 and 12 X 10(6) U/m2 among 31 and 30 patients, respectively." @default.
- W1765288714 created "2016-06-24" @default.
- W1765288714 creator A5021500567 @default.
- W1765288714 creator A5032917850 @default.
- W1765288714 creator A5035607232 @default.
- W1765288714 creator A5043035130 @default.
- W1765288714 creator A5061549536 @default.
- W1765288714 creator A5074002894 @default.
- W1765288714 date "1985-07-01" @default.
- W1765288714 modified "2023-09-24" @default.
- W1765288714 title "Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma." @default.
- W1765288714 cites W1502556912 @default.
- W1765288714 cites W1966218550 @default.
- W1765288714 cites W1995578078 @default.
- W1765288714 cites W1996549520 @default.
- W1765288714 cites W2052521829 @default.
- W1765288714 cites W2056102936 @default.
- W1765288714 cites W2057908608 @default.
- W1765288714 cites W2089433411 @default.
- W1765288714 cites W2110489989 @default.
- W1765288714 cites W2112515749 @default.
- W1765288714 cites W2128394628 @default.
- W1765288714 cites W2222203233 @default.
- W1765288714 cites W2269595883 @default.
- W1765288714 cites W2399193658 @default.
- W1765288714 cites W2413986234 @default.
- W1765288714 cites W3026394350 @default.
- W1765288714 cites W3027192968 @default.
- W1765288714 doi "https://doi.org/10.1200/jco.1985.3.7.977" @default.
- W1765288714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/4020408" @default.
- W1765288714 hasPublicationYear "1985" @default.
- W1765288714 type Work @default.
- W1765288714 sameAs 1765288714 @default.
- W1765288714 citedByCount "54" @default.
- W1765288714 countsByYear W17652887142013 @default.
- W1765288714 countsByYear W17652887142016 @default.
- W1765288714 countsByYear W17652887142019 @default.
- W1765288714 countsByYear W17652887142020 @default.
- W1765288714 countsByYear W17652887142021 @default.
- W1765288714 crossrefType "journal-article" @default.
- W1765288714 hasAuthorship W1765288714A5021500567 @default.
- W1765288714 hasAuthorship W1765288714A5032917850 @default.
- W1765288714 hasAuthorship W1765288714A5035607232 @default.
- W1765288714 hasAuthorship W1765288714A5043035130 @default.
- W1765288714 hasAuthorship W1765288714A5061549536 @default.
- W1765288714 hasAuthorship W1765288714A5074002894 @default.
- W1765288714 hasConcept C126322002 @default.
- W1765288714 hasConcept C141071460 @default.
- W1765288714 hasConcept C197934379 @default.
- W1765288714 hasConcept C2776694085 @default.
- W1765288714 hasConcept C2777658100 @default.
- W1765288714 hasConcept C2779384505 @default.
- W1765288714 hasConcept C2780580376 @default.
- W1765288714 hasConcept C2780873365 @default.
- W1765288714 hasConcept C502942594 @default.
- W1765288714 hasConcept C71924100 @default.
- W1765288714 hasConcept C90924648 @default.
- W1765288714 hasConceptScore W1765288714C126322002 @default.
- W1765288714 hasConceptScore W1765288714C141071460 @default.
- W1765288714 hasConceptScore W1765288714C197934379 @default.
- W1765288714 hasConceptScore W1765288714C2776694085 @default.
- W1765288714 hasConceptScore W1765288714C2777658100 @default.
- W1765288714 hasConceptScore W1765288714C2779384505 @default.
- W1765288714 hasConceptScore W1765288714C2780580376 @default.
- W1765288714 hasConceptScore W1765288714C2780873365 @default.
- W1765288714 hasConceptScore W1765288714C502942594 @default.
- W1765288714 hasConceptScore W1765288714C71924100 @default.
- W1765288714 hasConceptScore W1765288714C90924648 @default.
- W1765288714 hasIssue "7" @default.
- W1765288714 hasLocation W17652887141 @default.
- W1765288714 hasLocation W17652887142 @default.
- W1765288714 hasOpenAccess W1765288714 @default.
- W1765288714 hasPrimaryLocation W17652887141 @default.
- W1765288714 hasRelatedWork W141775729 @default.
- W1765288714 hasRelatedWork W1967315421 @default.
- W1765288714 hasRelatedWork W2351585609 @default.
- W1765288714 hasRelatedWork W2374636120 @default.
- W1765288714 hasRelatedWork W2378780384 @default.
- W1765288714 hasRelatedWork W2381290377 @default.
- W1765288714 hasRelatedWork W2399102665 @default.
- W1765288714 hasRelatedWork W2412468639 @default.
- W1765288714 hasRelatedWork W2468000090 @default.
- W1765288714 hasRelatedWork W3031583901 @default.
- W1765288714 hasVolume "3" @default.
- W1765288714 isParatext "false" @default.
- W1765288714 isRetracted "false" @default.
- W1765288714 magId "1765288714" @default.
- W1765288714 workType "article" @default.